Literature DB >> 14501160

Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor.

Tsuguka Shiwa1, Taku Amano, Hiroaki Matsubayashi, Takahiro Seki, Masashi Sasa, Norio Sakai.   

Abstract

To investigate the effect of cis-N-[4-[4-(1,2-benz-isozole-3-yl)-1-piperazinyl]butyl] cyclohexane-1,2-dicarboximide hydrochloride (perospirone), a novel antipsychotic agent with high affinities for D(2)/5-HT(2) receptors, on the rat dorsal raphe (DR) neurons, an electrophysiological study was performed using the tight-seal whole-cell patch-clamp technique. Applications of perospirone at the concentration between 10(-)(9) and 10(-)(5) M hyperpolarized the membrane potential and inhibited spontaneous action potentials of the DR neurons in a concentration-dependent manner. This effect of perospirone on DR neurons is similar to that of typical 5HT(1A)-receptor agonists, including 8-OH-DPAT or tandospirone. In addition, WAY100635, a 5-HT(1A)-receptor antagonist, inhibited this perospirone-induced hyperpolarization of DR neurons, suggesting that perospirone physiologically acts on DR neurons as a 5HT(1A)-receptor agonist. These results provide new profiles of perospirone as an antipsychotic drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501160     DOI: 10.1254/jphs.93.114

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  6 in total

1.  Role of 5-HT(1A) receptors in the modulation of stress-induced lactate metabolism in the medial prefrontal cortex and basolateral amygdala.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Tadasu Matsuoka; Hiroko Itoh; Masayoshi Kurachi
Journal:  Psychopharmacology (Berl)       Date:  2006-04-05       Impact factor: 4.530

2.  A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.

Authors:  Masafumi Yoshimura; Thomas Koenig; Satoshi Irisawa; Toshiaki Isotani; Keizo Yamada; Mitsuru Kikuchi; Gaku Okugawa; Takami Yagyu; Toshihiko Kinoshita; Werner Strik; Thomas Dierks
Journal:  Psychopharmacology (Berl)       Date:  2007-02-27       Impact factor: 4.530

Review 3.  Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.

Authors:  Adrian Newman-Tancredi; Mark S Kleven
Journal:  Psychopharmacology (Berl)       Date:  2011-03-11       Impact factor: 4.530

4.  Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.

Authors:  Yoshiteru Takekita; Chiara Fabbri; Masaki Kato; Shinpei Nonen; Shiho Sakai; Naotaka Sunada; Yosuke Koshikawa; Masataka Wakeno; Gaku Okugawa; Toshihiko Kinoshita; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-28       Impact factor: 5.270

5.  Long-term Efficacy and Tolerability of Perospirone for Young Help-seeking People at Clinical High Risk: a Preliminary Open Trial.

Authors:  Naohisa Tsujino; Takahiro Nemoto; Keiko Morita; Naoyuki Katagiri; Shinya Ito; Masafumi Mizuno
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

6.  Genetic polymorphisms in dopamine- and serotonin-related genes and treatment responses to risperidone and perospirone.

Authors:  Atsushi Tsutsumi; Tetsufumi Kanazawa; Hiroki Kikuyama; Gaku Okugawa; Hiroyuki Uenishi; Toshio Miyamoto; Naoki Matsumoto; Jun Koh; Kazuhiro Shinosaki; Toshifumi Kishimoto; Hiroshi Yoneda; Toshihiko Kinoshita
Journal:  Psychiatry Investig       Date:  2009-08-03       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.